S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Sun Pharma to buy Ranbaxy in $3.2 billion deal (2014/4/7)|
|Indian Shares Shrug Off Positive Data to End Lower (2014/3/13)|
|BlueMountain Capital Management, LLC Urges Minority Shareholders of Taro Pharmaceutical Industries Ltd. to Vote FOR BlueMountain's Independent External Nominees to the Board of Taro and AGAINST the Re-Election of Incumbent External Directors and All Interested-Party Proposals Involving Executive and Director Compensation (2014/3/20)|
|BlueMountain Capital Management Demands that Taro Pharmaceutical Industries LTD Publicly Disclose the Results of the Shareholder Vote Held at Its Annual General Meeting (2013/9/13)|
|IsZo Capital Urges Taro Board to Withdraw its Recommendation for the Re-Election of the Current Taro External Directors at 2013 Annual Shareholder Meeting; Supports Election of BlueMountain's Independent Nominees ()|
|BlueMountain Capital Management and IsZo Capital To Update Shareholders Regarding Lawsuit Against Taro Pharmaceutical Industries, Call for the Resignation of External Directors (2014/1/31)|
|UPDATE: Japan, China stocks rise; India slides again ()|
|UPDATE: Japan, China stocks rise; India slides again (2013/8/19)|
|Pfizer Reports Fourth-Quarter and Full-Year 2013 Results; Provides 2014 Financial Guidance (2014/1/28)|
|Intrexon Announces Annual Report and Fourth Quarter Financial Results (2014/3/31)|
Click above to view more mutual fund data and stats for 524715 - Sun Pharmaceuticals Industries Ltd..